Table 1 Baseline characteristics of NSTEMI patients stratified according to diabetic status and APG

Age (years)

61.0 ± 10.8

62.3 ± 11.9

62.9 ± 10.6

63.1 ± 11.6

Female (%)

87 (18.5)^§

39 (21.2)^§

44 (33.1)*^#

38 (36.9)*^#

Hypertension (%)

249 (53.0)^§

102 (55.4)^§

98 (73.7)*^#

70 (68.0)*^#

Hyperlipidemia (%)

93 (19.8)

42 (22.8)

36 (27.1)

31 (30.1)*

Smoking (%)

273 (58.1)^§

104 (56.5)^§

56 (42.1)*^#

45 (43.7)*^#

Prior MI (%)

54 (11.5)

25 (13.6)

19 (14.3)

15 (14.6)

Prior PCI (%)

40 (8.5)^§

24 (13)^§

30 (22.6)*^#

10 (9.7)^§

Prior CABG (%)

4 (0.9)

0 (0.0)

2 (1.5)

0 (0.0)

Killip class 3–4 (%)

28 (6.0)^#

23 (12.5)*

14 (10.5)

17 (16.5)*

Creatinine (mg/dL)

0.87 ± 0.21

0.87 ± 0.16

0.91 ± 0.24*

0.93 ± 0.29*^#

LVEF ≤ 40% (%)

26 (5.5)

18 (9.8)

7 (5.3)

12 (11.7)*

TC (mg/dL)

162.6 ± 40.4

164.1 ± 40.2

160.0 ± 41.1

160.0 ± 44.5

TG (mg/dL)

139.5 ± 61.3

140.9 ± 66.4

141.5 ± 71.4

142.1 ± 65.1

HDL (mg/dL)

40.5 ± 11.8

39.0 ± 9.5

38.5 ± 12.5

39.8 ± 11.8

LDL (mg/dL)

98.6 ± 35.1

99.7 ± 33.8

92.3 ± 37.6

92.4 ± 39.0

Triple vessel disease or LM (%)

196 (41.7)^§

90 (48.9)^§

82 (61.7)*^#

66 (64.1)*^#

Number of vessels treated

1.45 ± 0.7

1.5 ± 0.6

1.57 ± 0.7

1.54 ± 0.7

Number of stents implanted

2.17 ± 1.3

2.33 ± 1.2

2.14 ± 1.3

2.25 ± 1.0

LAD culprit lesion (%)

203 (43.2)

91 (49.5)^§

44 (33.1)*^#

41 (39.8)

TIMI 0/1flow pre‐PCI (%)

153 (32.6)

52 (28.3)^§

67 (50.4)*^#

32 (31.1)^§

 Aspirin

467 (99.4)

182 (98.9)

132 (99.2)

102 (99.0)

 Ticlopidine and clopidogrel

467 (99.4)

467 (99.4)

132 (99.2)

102 (99.0)

 Beta-blockers

407 (86.6)

146 (79.3)

116 (87.2)

84 (82.4)

 ACEI and ARB

391 (83.2)

157 (85.3)

116 (87.2)

95 (92.2)

 Statins

468 (99.6)

181 (98.4)

132 (99.2)

100 (98)

 CCB

45 (9.6)

22 (12.0)

13 (12.6)

13 (10.4)

 Oral hypoglycemic agent

0 (0)^{# §}

6 (3.3)*^§

112 (84.2)*^#

87 (84.5)*^#

 Insulin

0 (0)^{# §}

2 (1.1)*^§

15 (11.3)*^#

20 (19.4)*^#

 Medication at discharge, n (%)

453

164

120

83

 Aspirin

418 (92.3)

151 (92.1)

112 (93.3)

81 (97.6)

 Ticlopidine and clopidogrel

56 (12.4)

18 (11.0)

13 (10.8)

11 (13.3)

 Beta-blockers

254 (56.1)

108 (65.9)

76 (63.3)

50 (60.2)

 ACEI and ARB

225 (49.7)

85 (51.8)

76 (63.3)

46 (55.4)

 Statins

387 (85.4)

141 (86.0)

101 (84.2)

72 (86.7)

 CCB

65 (14.3)

27 (16.5)

26 (21.7)

17 (20.5)